[ Price : $8.95]
Two Cooley attorneys urge companies regulated by FDA to follow the guidelines in a 7/8 draft guidance on responding to misinformat...[ Price : $8.95]
FDA clears a DeepWell Digital Therapeutics 510(k) for its biofeedback software development kit for use in over-the-counter treatme...[ Price : $8.95]
Federal Register notice: FDA classifies whole exome sequencing devices into Class 2 (special controls).[ Price : $8.95]
Aisa Pharma wins an FDA orphan drug designation for its investigational drug AISA-021 (cilnidipine) and its use in treating system...[ Price : $8.95]
Federal Register notice: FDA classifies blood collection devices for cell-free nucleic acids into Class 2.[ Price : $8.95]
GSK says data from two clinical trials showed that depemokimab significantly reduces asthma exacerbations in patients with severe ...[ Price : $8.95]
FDA removes a partial clinical hold against Rezolutes RZ358 (ersodetug), an investigational drug for treating hypoglycemia caused ...[ Price : $8.95]
FDA clears a Femasys 510(k) for its diagnostic device for checking the fallopian tubes to confirm permanent birth control placemen...